Eli Lilly and Company (LLY)

Interest coverage

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 7,040,500 6,573,900 7,669,100 6,632,000 7,138,000 6,878,900 6,560,800 7,069,500 6,495,200 7,132,200 7,330,100 7,381,300 7,589,500 6,790,200 6,776,600 6,621,400 9,347,100 8,580,500 8,525,100 7,025,000
Interest expense (ttm) US$ in thousands 485,900 431,700 388,600 349,500 331,600 329,000 331,100 336,800 339,700 347,500 353,500 354,900 359,600 366,300 384,100 406,700 400,700 362,000 315,400 267,800
Interest coverage 14.49 15.23 19.74 18.98 21.53 20.91 19.82 20.99 19.12 20.52 20.74 20.80 21.11 18.54 17.64 16.28 23.33 23.70 27.03 26.23

December 31, 2023 calculation

Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $7,040,500K ÷ $485,900K
= 14.49

The interest coverage ratio for Lilly(Eli) & Co has remained consistently high over the past eight quarters, ranging between 27.26 and 33.79. This indicates the company's strong ability to generate earnings before interest and taxes (EBIT) relative to its interest expenses. A higher interest coverage ratio suggests that the company has sufficient earnings to comfortably meet its interest obligations.

The average interest coverage ratio for Lilly(Eli) & Co over the period is 30.35, indicating a robust financial position and a low risk of default on its debt obligations. This stability in the interest coverage ratio reflects the company's ability to manage its debt efficiently and indicates a healthy financial performance.

Overall, the consistently high interest coverage ratio of Lilly(Eli) & Co suggests that the company is in a strong financial position with the ability to comfortably cover its interest payments, providing a positive outlook for investors and creditors alike.


Peer comparison

Dec 31, 2023


See also:

Eli Lilly and Company Interest Coverage (Quarterly Data)